Pharmaceuticals, Biotechnology and Life Sciences
ATHENS, Greece & BELOIT, Wisc.–(BUSINESS WIRE)–BIOEMTECH, a developer of high-resolution PET and SPECT imaging systems for preclinical and translational research,…
New research findings to be presented at Digestive Disease Week 2026 demonstrate that NIM-1324 outperforms current IBD medications and establish…
—Industry veteran brings global regulatory expertise to support development of innovative optogenetic gene therapies— BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics, a clinical-stage…
Appointment strengthens Artis platform strategy in nucleic acid medicines in connection with pending Syngoi acquisition SAN DIEGO–(BUSINESS WIRE)–Artis BioSolutions today…
Noninvasive CyPath® Lung test has shown 92% sensitivity, 87% specificity and 88% accuracy for detecting lung cancer in small nodules…
Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseases Achievement…
– Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases – – Initiation…
Nationally recognized public health leader and former Director of the CDC to provide strategic guidance on GX-03 development, the Company’s…
First-in-human data for long-acting formulations of VH184, the first third-generation integrase inhibitor, and early data for capsid inhibitor VH499 to…
Full-year revenue increased 10% to $727 million; Full-year clinical revenue grew 15%, or 13% excluding the Pathline acquisition; Successfully resolved…